NCT05989945Active, not recruiting
HIDRAdenitis Suppurativa and HEART Disease
Source: ClinicalTrials.gov · Last updated 1 Aug 2025
Brief summary (registry, in English)
In a prospective observational cohort study (n = 250) the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and HS severity and determine whether these are prognostic markers of heart disease in patients suffering from hidradenitis suppurativa (HS).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 4 Aug 2023
- Start date
- 1 Aug 2023
- Primary completion date
- 6 Jan 2025
- Lead sponsor
- Herlev and Gentofte Hospital
- Diseases
- Heart failure, Coronary artery disease, Stroke
- NCT number
- NCT05989945
What you commit to
- Study type: Observational
- Planned participants: 250
- From 1 Aug 2023 to the primary completion date, 6 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients unable to cooperate to the study and/or study examinations
- Patients unable to understand and sign informed consent
Who the study is looking for
- Age ≥ 18 years
- Diagnosis of HS
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen Coordinator of this site? Confirm its status | Hellerup | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.